
Justin Leventhal
Senior Policy Analyst at RealClear Health
Senior Policy Analyst at The American Consumer Institute.
Articles
-
Mar 7, 2025 |
myjournalcourier.com | Justin Leventhal
Imagine walking to your local pharmacy — the one your family has trusted for years — only to find it shuttered. This is unfortunate for many Americans as pharmacies nationwide close their doors permanently. While multiple factors can contribute to a business closing, the additional costs Pharmacy Benefit Managers impose on pharmacies contribute to the problem.
-
Feb 26, 2025 |
amac.us | Justin Leventhal
Newsline , Society | | 7 Comments | Imagine walking to your local pharmacy — the one your family has trusted for years — only to find it shuttered.
-
Feb 26, 2025 |
dcjournal.com | Justin Leventhal
Imagine walking to your local pharmacy — the one your family has trusted for years — only to find it shuttered. This is unfortunate for many Americans as pharmacies nationwide close their doors permanently. While multiple factors can contribute to a business closing, the additional costs Pharmacy Benefit Managers (PBMs) impose on pharmacies contribute to the problem.
-
Feb 17, 2025 |
detroitnews.com | Justin Leventhal
Justin LeventhalThe Detroit NewsView Comments During his first term, President Donald Trump’s tariffs were an $80 billion tax on consumers, with most of these tariffs persisting under the Biden administration. The bill is looking to be higher this time as tariffs are being applied more broadly. Until now, the pharmaceutical industry has primarily avoided the direct effects of these levies.
-
Feb 7, 2025 |
oaoa.com | Justin Leventhal
By Justin LeventhalInsideSources.comDuring his first term, President Trump’s tariffs were an $80 billion tax on consumers, with most of these tariffs persisting under the Biden administration. The bill is looking to be higher this time as tariffs are being applied more broadly. Until now, the pharmaceutical industry has primarily avoided the direct effects of these levies. That is changing in Trump’s second term, with tariffs set to increase the cost of medicine along with everything else.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 77
- Tweets
- 342
- DMs Open
- No

RT @consumerpal: 💊 The 340B Drug Pricing Program, designed to aid vulnerable patients, is facing scrutiny. Critics argue that some hospital…

RT @tzduren: I will be tuning and and live tweeting some of the FTC’s event on the attention economy. My hope is to share research and pers…

RT @consumerpal: Health insurance was meant to cover risk, not routine checkups. Direct Primary Care (DPC) is fixing that—cutting out middl…